Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy and safety of gefitinib combinated with
Pemetrexed/Cisplatin in advanced non-small cell lung cancer (NSCLC).